Teduglutide and short bowel syndrome: Every night without parenteral fluids is a good night

Gastroenterology

Volumn 143, Issue 6, 2012, Pages 1416-1420

  Buchman, Alan L ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; BETA CATENIN; CHOLECYSTOKININ; ELECTROLYTE; EPIDERMAL GROWTH FACTOR; GASTRIN; GLUCAGON LIKE PEPTIDE 2; GLYCINE; INSULIN; KERATINOCYTE GROWTH FACTOR; NEUROTENSIN; PLACEBO; SCATTER FACTOR; SOMATOMEDIN C; TEDUGLUTIDE; TRANSFORMING GROWTH FACTOR; VASCULOTROPIN; WNT PROTEIN;

ACROMEGALY; ARTIFICIAL FEEDING; COLON ADENOMA; COLONOSCOPY; CROHN DISEASE; DRUG DOSE COMPARISON; FOOD AND DRUG ADMINISTRATION; GASTROSCHISIS; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; INTESTINAL FAILURE; INTESTINE ABSORPTION; INTESTINE ATRESIA; INTESTINE TRANSIT TIME; INTESTINE VOLVULUS; KIDNEY TUBULE ABSORPTION; LIVER TRANSPLANTATION; MALROTATION SYNDROME; MESENTERY BLOOD FLOW; PARENTERAL NUTRITION; PATIENT CARE; PRIORITY JOURNAL; REVIEW; SHORT BOWEL SYNDROME; SMALL INTESTINE RESECTION; STOMACH EMPTYING; TREATMENT RESPONSE;

EID: 84869814284     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.10.022     Document Type: Editorial

References (42)

1. B. Borgstrom, A. Dahlqvist, G. Lundh Studies of intestinal digestion and absorption in the human J Clin Invest 36 1957 1521 1536
2. J.M. Nightingale, J.E. Lennard-Jones, E.R. Walker Jejunal efflux in SBS Lancet 336-8 1990 765 768
3. A.L. Buchman Short bowel syndrome M. Feldman, L.S. Friedman, L.S. Brandt, Sleisenger and Fordtran's gastrointestinal and liver disease 9th ed. 2010 Saunders Philadelphia 1779 1796
4. A.L. Buchman, K. Iyer, J. Fryer Parenteral nutrition-associated liver disease and the role for isolated intestine and intestine/liver transplantation Hepatology 43 2006 9 19
5. Howard L, Home parenteral nutrition: survival, cost, and quality of life. Gastroenterology. Feb;130(2 Suppl 1):S52-S59.
6. R.C.N. Williamson, M. Chir Intestinal adaptation I. Structural, functional and cytokinetic changes N Engl J Med 298 1978 1393 1402
7. R.C.N. Williamson, M. Chir Intestinal adaptation II. Mechanisms of control N Engl J Med 298 1978 1444 1450
8. G.V.N. Appleton, J.B. Bristol, R.C.N. Williamson Proximal enterectomy provides a stronger systemic stimulus to intestinal adaptation than distal enterectomy Gut 28 1987 165 168
9. J.H. Solhaug, S. Tvete Adaptive changes in the small intestine following bypass operation for obesity Scand J Gastroenterol 13 1978 401 408
10. E. Levy, P. Frileux, S. Sandrucci Continuous enteral nutrition during the early adaptive stage of the SBS Br J Surg 75 1988 549 553
11. M. Chaves, M.W. Smith, R.C.N. Williamson Increased activity of digestive enzymes in ileal enterocytes adapting to proximal small bowel resection Gut 28 1987 981 987
12. M.C. Gouttebel, B. Saint Aubert, C. Colette Intestinal adaptation in patients with SBS Dig Dis Sci 34 1989 709 715
13. A.L. Buchman, J. Scolapio, J. Fryer AGA technical review on short bowel syndrome and intestinal transplantation Gastroenterology 124 2003 1111 1134
14. J. Scolapio, A.L. Buchman, M. Floch Education of gastroenterology trainees: first annual fellows' nutrition course J Clin Gastroenterol 42 2008 122 127
15. B. Messiing, M. Lemann, P. Landais Prognosis of patients with nonmalignant chronic intestinal failure receiving long-term home parenteral nutrition Gastroenterology 108 1995 1005 1010
16. T.A. Byrne, D.W. Wilmore, K. Iyer Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome: a prospective, randomized, placebo-controlled, double-blind clinical trial Ann Surg 242 2005 655 661
17. G. Johannsson, Y.B. Sverrisdottir, L. Ellegard GH increases extracellular volume by stimulating sodium reabsorption in the distal nephron and preventing pressure natriuresis J Clin Endocrinol Metab 87 2002 1743 1749
18. D. Dworakowska, M. Gueorguiev, P. Kelly Repeated colonoscopic screening of patients with acromegaly: 15-year experience identifies those at risk of new colonic neoplasia and allows for effective screening guidelines Eur J Endocrinol 163 2010 21 28
19. J.J. Cisler, A.L. Buchman Intestinal adaptation in short bowel syndrome J Investig Med 53 2005 402 413
20. K. Bulut, J.J. Meier, N. Ansorge Glucagon-like peptide 2 improves intestinal wound healing through induction of epithelial cell migration in vitro-evidence for a TGF-beta-mediated effect Regul Pept 121 2004 137 143
21. C. Orskov, B. Hartmann, S.S. Poulsen GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors Regul Pept 124 2005 105 112
22. P.E. Dube, C.L. Forse, J. Bahrami The essential role of insulin-like growth factor in the intestinal tropic effects of glucagon-like peptide-2 in mice Gastroenterology 131 2006 589 605
23. P.B. Jeppesen, B. Hartman, B.S. Hansen Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure Gut 45 1999 559 563
24. P.B. Jeppesen, B. Hartmann, J. Thulsen Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon Gut 47 2000 370 376
25. P.E. Dube, K.J. Rowland, P.L. Brubaker Glucagon-like peptide-2 activates β-catenin signaling in the mouse intestinal crypt: role of insulin-like growth factor-1 Endocrinology 49 2008 291 301
26. L. Bremholm, M. Horum, B.M. Henriksen Glucagon-like peptide-2 increases mesenteric blood flow in humans Scand J Gastroenterol 44 2009 314 319
27. P.L. Brubaker, D.J. Drucker, S.L. Sas Prolonged gastrointestinal transit in a patients with a glucagon-like peptide (GLP-1- and -2-producing neuroendocrine tumor J Clin Endocrinol Metab 87 2002 3078 3083
28. M. Lauverjat, A.A. Hadj, P. Vanhems Chronic dehydration may impair renal function in patients with chronic intestinal failure on long-term parenteral nutrition Clin Nutr 25 2006 75 81
29. P.B. Jeppesen, I. Gottschalck, J.J. Holst Improvements in renal function in short bowel syndrome (SBS) patients treated for two years with subcutaneous native glucagon-like peptide 2 (GLP-2) [abstr] Gastroenterology 134 2008 A427 A428
30. K.V. Haderslev, P.B. Jeppesen, B. Hartmann Short-term administration of glucagon-like peptide-2 Effects on bone mineral density and markers of bone turnover in short-bowel patients with no colon Scand J Gastroenterol 37 2002 392 398
31. A.L. Buchman, A. Moukarzel Metabolic bone disease associated with parenteral nutrition Clin Nutr 19 2000 217 231
32. P.B. Jeppesen, M. Pertkiewicz, B. Messing Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure Gastroenterology 143 2012 1473 1481
33. P.B. Jeppesen, R.Pertkiewicz Gilroy Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome Gut 60 2011 902 914
34. P.B. Jeppesen, E.L. Sanguinetti, A. Buchman Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients Gut 54 2005 1224 1231
35. A.L. Buchman, S. Katz, J.C. Fang Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohn's disease Inflamm Bowel Dis 16 2010 962 973
36. D.L. Sigalet, G. Martin, J. Meddings GLP-2 levels in infants with intestinal dysfunction Pediatr Res 56 2004 371 376
37. J. Thulesen, B. Hartmann, K.J. Hare Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice Gut 53 2004 1145 1150
38. J.A. Koehler, W. Harper, M. Barnard Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells Cancer Res 68 2008 7897 7904
39. R. Lakoubov, L.M. Lauffer, S. Trivedi Carcinogenic effects of exogenous and endogenous glucagon-like peptide-2 in azoxymethane-treated mice Endocrinology 150 2009 4033 4043
40. B. Yusta, L. Huang, D. Munroe Enteroendocrine localization of GLP-2 receptor expression in humans and rodents Gastroenterology 119 2000 744 755
41. C. Compher, R. Gilroy, M. Pertkiewicz Maintenance of parenteral nutrition volume reduction, without weight loss, after stopping teduglutide in a subset of patients with short bowel syndrome J Parenteral Enteral Nutr 35 2011 603 609
42. L. Schwartz, D. Seidner, P.B. Jeppesen Teduglutide for the treatment of short bowel syndrome-intestinal failure subjects yields further reductions in parenteral support: an interim assessment of a 2-year, open-label, phase 3 trial (STEPS2) (abstr) Am J Gastroenterol 106 2011 S99